Spondin 1 Enriched in p16Ink4a Reporter-Labeled Fibroblasts Promotes Melanoma Cell Proliferation in Vitro and Is Associated with Poor Prognosis
Year: 2026
Type: article
Abstract: The tumor microenvironment contains phenotypically diverse stromal cells that can support tumor progression; however, the identity and function of stromal populations expressing the senescence marker p16Ink4a in melanoma remain poorly defined. We combined p16-CreERT2-tdTomato lineage tracing with single-cell RNA sequencing in a syngeneic YUMMER1.7-H2B-GFP5 melanoma model to characterize p16Ink4a-lineage-positive [p16-Lin(+)] stromal cells and identify candidate mediators of tumor–stroma interactions. Immunofluorescence detected p16-Lin(+) cells across multiple stromal populations, while transcriptomic analysis identified fibroblasts as a major p16-Lin(+) stromal population. The integration of differentially expressed genes in p16-Lin(+) fibroblasts with a secretome database and survival data from The Cancer Genome Atlas Skin Cutaneous Melanoma cohort identified spondin 1 (SPON1) as a candidate extracellular mediator. Spon1 was preferentially expressed in fibroblasts, upregulated in the p16-Lin(+) fraction, and nearly undetectable in YUMMER1.7-H2B-GFP5 cells. Immobilized recombinant SPON1 promoted YUMM1.7 cell proliferation in a dose-dependent manner in vitro. In an independent human skin tumor single-cell dataset, SPON1 expression was enriched in fibroblasts, with higher enrichment observed in those expressing CDKN2A, which encodes p16INK4A. Moreover, high SPON1 expression was independently associated with shorter overall survival after adjusting for tumor type, age, and sex. Together, these findings identify SPON1 as a candidate factor enriched in p16-Lin(+) fibroblasts, with potential functional and prognostic relevance in melanoma.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Funders: Cell Science Research Foundation, Japan Agency for Medical Research and Development, Cancer Research Institute, Kanazawa University, Ministry of Education, Culture, Sports, Science and Technology, Secom Science and Technology Foundation, University of Tokyo, Daiichi Sankyo Foundation of Life Science, Japan Society for the Promotion of Science, Japan Science and Technology Agency
Awards: G1537473496, 『一過性の老化細胞』と『慢性の老化細胞』の違いを生み出すメカニズムの解明, 肝発がんを予測、予防する新規診断治療法の開発研究, G2340187628, 細胞種特異的な老化細胞制御システムを用いた個体老化・加齢性疾患病態機構の解明, G3107535564, G3218309745, Integrated understanding of cell-cell interaction mechanisms underlying brain dysfunction common to brain aging and neurological disorders, G4073361332, 老化細胞リプログラミング機構の解明による加齢組織再生法の創出, G4353692892, G4583585075, G5257508400, G5266575847, 急性肝障害からの再生におけるp16陽性肝細胞の動態・性状解析, G8349094663, 加齢に伴うプロテオスタシス破綻のメカニズム解明に基づく老化制御法の開発
OpenAlex ID: W7221042431
